Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-TAMS in Adult ADHD
NCT02558790Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2016
- Primary completion
- Oct 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Magnesium L-threonate in attention deficit hyperactivity disorder (ADHD), sponsored by Massachusetts General Hospital. Started Mar 2016; status: completed.
02
Drugs
Magnesium L-threonate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02558790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02558790.